FINWIRES · TerminalLIVE
FINWIRES

Zydus Lifesciences Receives USFDA Warning Letter for Baddi Facility

By

Zydus Lifesciences (NSE:ZYDUSLIFE, BOM:532321) said it received a warning letter from the U.S. Food and Drug Administration related to its formulations manufacturing facility in Baddi, Himachal Pradesh, according to a Wednesday filing on Indian bourses.

The warning letter was issued in response to a records request under the Federal Food, Drug, and Cosmetic Act, the company said. It relates to observations regarding the use of purified talc that did not meet current U.S. Pharmacopeia requirements.

Zydus said the letter is not linked to an on-site inspection and does not affect current operations or supplies from the facility.

Related Articles

Asia

GCH Technology Unit to Invest 1.3 Billion Yuan in Dongguan Electronic Materials Complex

GCH Technology's (SHA:688625) subsidiary, Guangdong Chenghe Electronic Materials, will invest up to 1.3 billion yuan to construct a high-frequency, high-speed electronic materials and high-end additives project.The subsidiary will construct the facility in Dongguan, Guangdong, China, according to a Wednesday filing with the Shanghai bourse.The complex will have a total land area of ​​140,980 square meters and will be constructed within 18 months.

$SHA:688625
Asia

Meitec to Record 14.6 Billion Yen in Dividend Income From Subsidaries

Meitec (TYO:9744) will receive dividends totalling 14.6 billion yen from four consolidated subsidiaries, effective June 4, according to a Tokyo bourse filing on Wednesday.The dividends were resolved on June 3, with Meitec Corp. contributing the largest share at 11.4 billion yen.As a result, the company will record the full dividend amount as operating income in its non-consolidated financial results for the current fiscal year.However, since these are intra-group dividends, there will be no impact on the consolidated financial results.

$TYO:9744
Asia

Shanghai Bourse Approves Hubei Zhenhua Chemical's Corporate Bond Issuance

The Shanghai Stock Exchange approved Hubei Zhenhua Chemical's (SHA:603067) corporate bond issuance, according to a Wednesday bourse filing.China's securities regulator will ultimately approve the issuance.Zhenhua is set to use the proceeds, set at 878 million yuan, to co-produce 5,000 tons per year of vitamin K3 and 74,000 tons per year of chromium green, as well as 500,000 tons per year of sulfuric acid and to 50,000 tons per year of chromium powder, according to a Jan. 5, 2026 filing.

$SHA:603067